Neurath MF - Search Results

1

NF-kappaB in inflammatory bowel disease.

Atreya I, Atreya R, Neurath MF. Atreya I, et al. Among authors: neurath mf. J Intern Med. 2008 Jun;263(6):591-6. doi: 10.1111/j.1365-2796.2008.01953.x. J Intern Med. 2008. PMID: 18479258 Review.

2

The tumor suppressor CYLD controls the function of murine regulatory T cells.

Reissig S, Hövelmeyer N, Weigmann B, Nikolaev A, Kalt B, Wunderlich TF, Hahn M, Neurath MF, Waisman A. Reissig S, et al. Among authors: neurath mf. J Immunol. 2012 Nov 15;189(10):4770-6. doi: 10.4049/jimmunol.1201993. Epub 2012 Oct 12. J Immunol. 2012. PMID: 23066153

3

TNBS-colitis.

Neurath M, Fuss I, Strober W. Neurath M, et al. Int Rev Immunol. 2000;19(1):51-62. doi: 10.3109/08830180009048389. Int Rev Immunol. 2000. PMID: 10723677 Review.

4

T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Büschenfelde KH. Duchmann R, et al. Gut. 1999 Jun;44(6):812-8. doi: 10.1136/gut.44.6.812. Gut. 1999. PMID: 10323882 Free PMC article.

5

Normal interleukin-12 production in individuals with antibodies to Helicobacter pylori.

Duchmann R, Scherer H, Neurath M, Knolle P, Meyer zum Büschenfelde KH. Duchmann R, et al. APMIS. 1997 Nov;105(11):824-30. doi: 10.1111/j.1699-0463.1997.tb05090.x. APMIS. 1997. PMID: 9393552

6

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH, Neurath M. Duchmann R, et al. Eur J Immunol. 1996 Apr;26(4):934-8. doi: 10.1002/eji.1830260432. Eur J Immunol. 1996. PMID: 8625991

7

Immune responses towards intestinal bacteria--current concepts and future perspectives.

Duchmann R, Neurath M, Märker-Hermann E, Meyer Zum Büschenfelde KH. Duchmann R, et al. Z Gastroenterol. 1997 May;35(5):337-46. Z Gastroenterol. 1997. PMID: 9188147 Review.

8

[Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].

Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M. Holtmann M, et al. Z Gastroenterol. 2003 Jan;41(1):11-7. doi: 10.1055/s-2003-36677. Z Gastroenterol. 2003. PMID: 12541166 German.

9

Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease.

Kiesslich R, Duckworth CA, Moussata D, Gloeckner A, Lim LG, Goetz M, Pritchard DM, Galle PR, Neurath MF, Watson AJ. Kiesslich R, et al. Among authors: neurath mf. Gut. 2012 Aug;61(8):1146-53. doi: 10.1136/gutjnl-2011-300695. Epub 2011 Nov 24. Gut. 2012. PMID: 22115910 Free PMC article.

10

What new endoscopic imaging modalities will become important in the diagnosis of IBD?

Kiesslich R, Neurath MF. Kiesslich R, et al. Among authors: neurath mf. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S172-6. doi: 10.1002/ibd.20715. Inflamm Bowel Dis. 2008. PMID: 18816714 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results